Wolfe Research Adjusts Price Target on CVS Health to $64 From $70, Keeps Outperform Rating
CVS Health Analyst Ratings
CVS Health Analyst Ratings
JP Morgan Maintains Overweight on CVS Health, Lowers Price Target to $86
JPMorgan Adjusts Price Target on CVS Health to $86 From $101
CVS Health (CVS) Receives a Hold From Wells Fargo
CVS Health Analyst Ratings
Wolfe Research Lowers CVS Health's Price Target to $64 From $70
Buy Rating Affirmed: CVS Health's Proactive Strategies Counter Medicare Advantage Pressures and Unlock Growth Opportunities
Argus Research Sticks to Its Buy Rating for CVS Health (CVS)
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Argus Research Maintains Buy on CVS Health, Lowers Price Target to $80
CVS Health Analyst Ratings
Argus Research Adjusts Price Target on CVS Health to $80 From $100
CVS Health Analyst Ratings
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76
CVS Health Analyst Ratings
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91
CVS Health Analyst Ratings
CVS Health (CVS) Receives a Rating Update From a Top Analyst